Creator: Dan Keller
Duration: 5:20
Journal: Oncology Times
Jedd Wolchok, MD, elaborates on his presentation at the 10th International Meeting of the Society for Melanoma Research about the need for therapies for melanoma beyond current CTLA-4 blockade, findings on biomarkers for response, PD-L1 expression as a biomarker on tumor cells, and the potential for targeted combination treatments.